{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:24:49Z","timestamp":1787066689509,"version":"build-2736575974"},"reference-count":133,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Philadelphia-negative chronic myeloproliferative neoplasms (MPNs) have recently been revealed to be related to chronic inflammation, oxidative stress, and the accumulation of reactive oxygen species. It has been proposed that MPNs represent a human inflammation model for tumor advancement, in which long-lasting inflammation serves as the driving element from early tumor stage (over polycythemia vera) to the later myelofibrotic cancer stage. It has been theorized that the starting event for acquired stem cell alteration may occur after a chronic inflammation stimulus with consequent myelopoietic drive, producing a genetic stem cell insult. When this occurs, the clone itself constantly produces inflammatory components in the bone marrow; these elements further cause clonal expansion. In BCR\u2013ABL1-negative MPNs, the driver mutations include JAK 2, MPL, and CALR. Transcriptomic studies of hematopoietic stem cells from subjects with driver mutations have demonstrated the upregulation of inflammation-related genes capable of provoking the development of an inflammatory state. The possibility of acting on the inflammatory state as a therapeutic approach in MPNs appears promising, in which an intervention operating on the pathways that control the synthesis of cytokines and oxidative stress could be effective in reducing the possibility of leukemic progression and onset of complications.<\/jats:p>","DOI":"10.3390\/antiox9111037","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T08:59:28Z","timestamp":1603443568000},"page":"1037","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR\u2013ABL-Negative Myeloproliferative Neoplasm"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-8239","authenticated-orcid":false,"given":"Alessandro","family":"Allegra","sequence":"first","affiliation":[{"name":"Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, Division of Hematology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8089-7449","authenticated-orcid":false,"given":"Giovanni","family":"Pioggia","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8335-5541","authenticated-orcid":false,"given":"Alessandro","family":"Tonacci","sequence":"additional","affiliation":[{"name":"Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-1501","authenticated-orcid":false,"given":"Marco","family":"Casciaro","sequence":"additional","affiliation":[{"name":"School and Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Musolino","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, Division of Hematology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[{"name":"School and Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","article-title":"Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies","volume":"29","author":"Tefferi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: Is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102476","DOI":"10.1155\/2015\/102476","article-title":"MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives","volume":"2015","author":"Hasselbalch","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"964613","DOI":"10.1155\/2015\/964613","article-title":"Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art","volume":"2015","author":"Hermouet","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative neoplasms and inflammation: Whether to target the malignant clone or the inflammatory process or both","volume":"30","author":"Koschmieder","year":"2016","journal-title":"Leukemia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.leukres.2009.04.038","article-title":"Does oxidative damage contribute to the generation of leukemia?","volume":"33","author":"Austin","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNF\u03b1 facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3324\/haematol.2011.055392","article-title":"The JAK2 46\/1 haplotype: A marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?","volume":"96","author":"Hermouet","year":"2011","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1182\/blood-2011-01-326025","article-title":"Do reactive oxygen species play a role in myeloid leukemias?","volume":"117","author":"Hole","year":"2011","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: A key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras","year":"2017","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: Different role of C-reactive protein and pentraxin 3","volume":"96","author":"Barbui","year":"2011","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","article-title":"The role of cytokines in the initiation and progression of myelofibrosis","volume":"24","author":"Hasselbalch","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ajh.23406","article-title":"Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis","volume":"88","author":"Pardanani","year":"2013","journal-title":"Am. J. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.leukres.2012.07.009","article-title":"Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance","volume":"36","author":"Skov","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.exphem.2012.05.011","article-title":"Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis","volume":"40","author":"Skov","year":"2012","journal-title":"Exp. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wong, W.J., Baltay, M., Getz, A., Fuhrman, K., Aster, J.C., Hasserjian, R.P., and Pozdnyakova, O. (2019). Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216810"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Longhitano, L., and Li Volti, G. (2020). The Role of Inflammation and Inflammasome in Myeloproliferative Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082334"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40164-016-0032-7","article-title":"Identification of AIM2 as a downstream target of JAK2V617F","volume":"5","author":"Liew","year":"2015","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK\u2013STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2014-12-618595","article-title":"Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells","volume":"126","author":"Lu","year":"2015","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1172\/JCI64397","article-title":"Spleens of myelofibrosis patients contain malignant hematopoietic stem cells","volume":"122","author":"Wang","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood.V128.22.953.953","article-title":"Splenic Micro Environmental Cells from Patients with Myelofibrosis Elaborate a Cascade of Cytokines and Serve as a Niche for Malignant Hematopoiesis","volume":"128","author":"Lu","year":"2016","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Goldstein, L.J., Perez, R.P., Yardley, D.A., Han, L.K., Reuben, J.M., McCanna, S., Butler, B., Ruffini, P.A., and Chang, J.C. (2016, January 16\u201320). Abstract CT057: A single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery. Proceedings of the AACR 107th Annual Meeting 2016, Clinical Trials, New Orleans, LA, USA.","DOI":"10.1158\/1538-7445.AM2016-CT057"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/19382014.2016.1199303","article-title":"Reparixin, a CXCR1\/2 inhibitor in islet allotransplantation","volume":"8","author":"Pawlick","year":"2016","journal-title":"Islets"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","article-title":"The interleukin-12\/interleukin-12-receptor system: Role in Normal and Pathologic Immune Responses","volume":"16","author":"Gately","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cyto.2015.09.011","article-title":"Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis","volume":"89","author":"Qian","year":"2017","journal-title":"Cytokine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc3565","article-title":"Gene-engineered T cells for cancer therapy","volume":"13","author":"Kershaw","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.htct.2017.12.003","article-title":"Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation","volume":"40","author":"Cacemiro","year":"2018","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1097\/HS9.0000000000000371","article-title":"Longitudinal Cytokine Profiling Identifies GRO-\u03b1 and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia","volume":"4","author":"Grinfeld","year":"2020","journal-title":"Hemasphere"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1097\/HS9.0000000000000407","article-title":"Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?","volume":"4","author":"Hasselbalch","year":"2020","journal-title":"Hemasphere"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/asheducation-2005.1.195","article-title":"A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative Diseases","volume":"2005","author":"Vainchenker","year":"2005","journal-title":"Hematology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1073\/pnas.1821068116","article-title":"Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers","volume":"116","author":"Ji","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","unstructured":"Nandi, B., Talluri, S., Kumar, S., Yenumula, C., Gold, J.S., Prabhala, R., Munshi, N.C., and Shammas, M.A. (2019). The roles of homologous recombination and the immune system in the genomic evolution of cancer. J. Transl. Sci., 5."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.1073\/pnas.2232790100","article-title":"SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer","volume":"100","author":"He","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.2009.184176","article-title":"Disease-related expression of the IL6\/STAT3\/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis","volume":"59","author":"Li","year":"2009","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am. J. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000477253","article-title":"Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis","volume":"40","author":"Barabanshikova","year":"2017","journal-title":"Oncol. Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/07357907.2011.629383","article-title":"Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia","volume":"30","author":"Gangemi","year":"2012","journal-title":"Cancer Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1852517","DOI":"10.1155\/2017\/1852517","article-title":"Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: The role of cytokines in multiple myeloma","volume":"2017","author":"Musolino","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Allegra, A., Innao, V., Allegra, A.G., Pugliese, M., Di Salvo, E., Ventura-Spagnolo, E., Musolino, C., and Gangemi, S. (2019). Lymphocyte subsets and inflammatory cytokines of monoclonal gammopathy of undetermined significance and multiple myeloma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112822"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.exphem.2010.07.005","article-title":"Oxidative stress is increased in primary and post\u2212polycythemia vera myelofibrosis","volume":"38","author":"Vener","year":"2010","journal-title":"Exp. Hematol."},{"key":"ref_49","first-page":"2860","article-title":"Increased oxidative stress in patients with essential thrombocythemia","volume":"17","author":"Durmus","year":"2013","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.clinbiochem.2012.07.100","article-title":"Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia","volume":"45","author":"Musolino","year":"2012","journal-title":"Clin. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-\u03baB: Linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-\u03baB activation by reactive oxygen species: Fifteen years later","volume":"72","author":"Gloire","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Karin","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","article-title":"Suppressors of cytokine signalling (SOCS) in the immune system","volume":"2","author":"Alexander","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"630797","DOI":"10.1155\/2014\/630797","article-title":"The role of suppressors of cytokine signalling in human neoplasms","volume":"2014","author":"Sasi","year":"2014","journal-title":"Mol. Biol. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.2008.07072.x","article-title":"Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders","volume":"141","author":"Capello","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3324\/haematol.13043","article-title":"Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders","volume":"93","author":"Fourouclas","year":"2008","journal-title":"Haematologica"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/leu.2013.102","article-title":"A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression","volume":"27","author":"Marty","year":"2013","journal-title":"Leukemia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3324\/haematol.2012.082560","article-title":"Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation","volume":"98","author":"Boussetta","year":"2013","journal-title":"Haematologica"},{"key":"ref_60","first-page":"794","article-title":"Production of large amounts of hydrogen peroxide by human tumor cells","volume":"51","author":"Szatrowski","year":"1991","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2003.05303.x","article-title":"Oxidative stress in malignant melanoma and non-melanoma skin cancer","volume":"148","author":"Sander","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34643","DOI":"10.1074\/jbc.M400078200","article-title":"Reactive Oxygen Species Produced by NAD (P) H Oxidase Inhibit Apoptosis in Pancreatic Cancer Cells","volume":"279","author":"Vaquero","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/sj.onc.1209406","article-title":"Inhibition of NADPH oxidase 4 activates apoptosis via the AKT\/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells","volume":"25","author":"Mochizuki","year":"2006","journal-title":"Oncogene"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10620-006-9177-2","article-title":"Enhanced Oxidative Stress and Leucocyte Activation in Neoplastic Tissues of the Colon","volume":"52","author":"Rainis","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejso.2006.10.024","article-title":"Differential expression of manganese superoxide dismutase, copper\/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa","volume":"33","author":"Hwang","year":"2007","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.freeradbiomed.2006.11.032","article-title":"Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress","volume":"42","author":"Smith","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_67","first-page":"330","article-title":"Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients","volume":"15","author":"Zelen","year":"2010","journal-title":"JBUON"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2015.06.017","article-title":"Regulation of catalase expression in healthy and cancerous cells","volume":"87","author":"Glorieux","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/onc.2011.313","article-title":"JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms","volume":"31","author":"Nakatake","year":"2011","journal-title":"Oncogene"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1227\/01.NEU.0000245590.08463.5B","article-title":"Variant of the chek2gene as a prognostic markerin glioblastoma multiforme","volume":"59","author":"Simon","year":"2006","journal-title":"Neurosurgery"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/humu.20321","article-title":"Characterization ofCHEK2 mutations in prostate cancer","volume":"27","author":"Wu","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_73","first-page":"583","article-title":"Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer","volume":"122","author":"Cybulski","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1002\/ijc.25003","article-title":"CHEK2 mutations and HNPCC-related colorectal cancer","volume":"126","author":"Suchy","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3324\/haematol.2011.049494","article-title":"A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations","volume":"97","author":"Janiszewska","year":"2012","journal-title":"Haematologica"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.13559","article-title":"The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera","volume":"173","author":"Janiszewska","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature01680","article-title":"Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate","volume":"423","author":"Salmeen","year":"2003","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1073\/pnas.0407396101","article-title":"Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors","volume":"101","author":"Kwon","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1021\/bi060157p","article-title":"Redox Regulation of MAP Kinase Phosphatase 3\u2020","volume":"45","author":"Seth","year":"2006","journal-title":"Biochemistry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2443.2003.00620.x","article-title":"Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway","volume":"8","author":"Iwasa","year":"2003","journal-title":"Genes Cells"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.exphem.2010.03.005","article-title":"Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway","volume":"38","author":"Lu","year":"2010","journal-title":"Exp. Hematol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood.V114.22.963.963","article-title":"FLT3-Mediated MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis","volume":"114","author":"Desterke","year":"2009","journal-title":"Blood"},{"key":"ref_83","first-page":"1481","article-title":"Oxidative and nitrosative stress in myeloproliferative neo-plasms: The impact on the AKT\/mTOR signaling pathway","volume":"23","author":"Djikic","year":"2018","journal-title":"JBUON"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Hasselbalch, H.C., Thomassen, M., Riley, C.H., Kj\u00e6r, L., Larsen, T.S., Jensen, M.K., Bjerrum, O.W., Kruse, T.A., and Skov, V. (2014). Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112786"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1568-7864(01)00007-6","article-title":"ATM deficiency and oxidative stress: A new dimension of defective response to DNA damage","volume":"1","author":"Barzilai","year":"2002","journal-title":"DNA Repair"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2007.02.001","article-title":"Foxo3a is Essential for Maintenance of the Hematopoietic Stem Cell Pool","volume":"1","author":"Miyamoto","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-\u03b2\u2013FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1272\/jnms.78.138","article-title":"Development and Maintenance of Cancer Stem Cells under Chronic Inflammation","volume":"78","author":"Tanno","year":"2011","journal-title":"J. Nippon Med. Sch."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.molcel.2019.01.009","article-title":"Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing","volume":"73","author":"Buck","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41375-018-0295-6","article-title":"JAK2V617F but not CALR mutations confer increased molecular responses to interferon-\u03b1 via JAK1\/STAT1 activation","volume":"33","author":"Czech","year":"2018","journal-title":"Leukemia"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kj\u00e6r, L., Cordua, S., Holmstr\u00f6m, M.O., Thomassen, M., Kruse, T.A., Pallisgaard, N., Larsen, T.S., de Stricker, K., Skov, V., and Hasselbalch, H.C. (2016). Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0165336"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/s41388-019-0813-7","article-title":"Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation","volume":"38","author":"Stetka","year":"2019","journal-title":"Oncogene"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood-2018-04-846220","article-title":"Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation","volume":"132","author":"Jacquelin","year":"2018","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2018-11-883470","article-title":"Accelerating myelofibrosis through loss of Dnmt3a","volume":"132","author":"Skoda","year":"2018","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/s41375-019-0379-y","article-title":"Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NF\u03baB signaling","volume":"33","author":"Fisher","year":"2019","journal-title":"Leukemia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/leu.2016.377","article-title":"Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia","volume":"31","author":"Fisher","year":"2017","journal-title":"Leukemia"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00432-017-2354-1","article-title":"Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN","volume":"143","author":"Eberhardt","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2018-08-872648","article-title":"CDK6 coordinates JAK2 (V617F) mutant MPN via NF-\u03baB and apoptotic networks","volume":"133","author":"Uras","year":"2019","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molcel.2013.12.002","article-title":"Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-\u03baB-Dependent Gene Expression","volume":"53","author":"Handschick","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3440281","article-title":"Calreticulin: One protein, one gene, many functions","volume":"344","author":"Michalak","year":"1999","journal-title":"Biochem. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.biocel.2012.02.009","article-title":"Calreticulin signaling in health and disease","volume":"44","author":"Wang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"C208","DOI":"10.1152\/ajpcell.00075.2005","article-title":"Role of calreticulin in the sensitivity of myocardiac H9c2 cells to oxidative stress caused by hydrogen peroxide","volume":"290","author":"Ihara","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/jid.2013.268","article-title":"Oxidative stress\u2013induced calreticulin expression and translocation: New insights into the destruction of melanocytes","volume":"134","author":"Zhang","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1158\/1078-0432.CCR-18-3777","article-title":"Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis","volume":"25","author":"Merlinsky","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12185-019-02800-0","article-title":"The role of calreticulin mutations in myeloproliferative neoplasms","volume":"111","author":"Araki","year":"2020","journal-title":"Int. J. Hematol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/carcin\/bgn188","article-title":"RAGE, carboxylated glycans and S100A8\/A9 play essential roles in colitis-associated carcinogenesis","volume":"29","author":"Turovskaya","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2013.10.036","article-title":"Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties","volume":"344","author":"Bettum","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s13402-018-0392-6","article-title":"TLR4 and RAGE conversely mediate pro-inflammatory S100A8\/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms","volume":"41","author":"Mossuz","year":"2018","journal-title":"Cell. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/10245332.2016.1163889","article-title":"Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C > T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms","volume":"21","author":"Trifa","year":"2016","journal-title":"Hematology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","article-title":"Gli1 (+) Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target","volume":"20","author":"Schneider","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2012-01-404889","article-title":"Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation","volume":"121","author":"Rosti","year":"2013","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/HS9.0000000000000106","article-title":"Inflammation and anti-inflammatory approaches in myeloproliferative neoplasm","volume":"2","author":"Koschmieder","year":"2018","journal-title":"HemaSphere"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2018.195321","article-title":"Vascular endothelial cell expression of JAK2 (V617F) is sufficient to promote a pro-thrombotic state due to increased P-selectin expression","volume":"104","author":"Guy","year":"2019","journal-title":"Haematologica"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0034-1370794","article-title":"Thrombosis in Myeloproliferative Neoplasms","volume":"40","author":"Marchetti","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fimmu.2019.01373","article-title":"Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms","volume":"10","author":"Heller","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2147\/OTT.S31916","article-title":"Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis","volume":"8","author":"Barosi","year":"2015","journal-title":"OncoTargets Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12967-018-1729-7","article-title":"The ruxolitinib effect: Understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms","volume":"16","author":"Greenfield","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: Therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Vaddi","year":"2010","journal-title":"Blood"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/10428194.2019.1579323","article-title":"Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis","volume":"60","author":"Brimnes","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"C1553","DOI":"10.1152\/ajpcell.00186.2003","article-title":"Role of Ca2+-activated K+ channels in human erythrocyte apoptosis","volume":"285","author":"Lang","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000334163","article-title":"Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes","volume":"33","author":"Lang","year":"2012","journal-title":"Blood Purif."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"C991","DOI":"10.1152\/ajpcell.00239.2012","article-title":"Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells","volume":"303","author":"Abed","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1159\/000430394","article-title":"Triggering of Suicidal Erythrocyte Death by Ruxolitinib","volume":"37","author":"Briglia","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3892\/ijo.2012.1647","article-title":"Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)","volume":"41","author":"Allegra","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/bjh.12828","article-title":"MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma","volume":"165","author":"Campo","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00277-018-3296-7","article-title":"Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw","volume":"97","author":"Musolino","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Allegra, A., Musolino, C., Tonacci, A., Pioggia, G., and Gangemi, S. (2020). Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities. Cancers, 12.","DOI":"10.3390\/cancers12040805"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/1878-0261.12387","article-title":"Role of TGF-\u03b21\/miR-382-5p\/SOD 2 axis in the induction of oxidative stress in CD 34+ cells from primary myelofibrosis","volume":"12","author":"Rossi","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/15592294.2016.1265710","article-title":"Bromodomain inhibitors and cancer therapy: From structures to applications","volume":"12","author":"Esteller","year":"2017","journal-title":"Epigenetics"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared Principles in NF-\u03baB Signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/leu.2016.260","article-title":"BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells","volume":"31","author":"Saenz","year":"2017","journal-title":"Leukemia"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/11\/1037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:26:57Z","timestamp":1760178417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/11\/1037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":133,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["antiox9111037"],"URL":"https:\/\/doi.org\/10.3390\/antiox9111037","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}